✦ LIBER ✦

63 CHARACTERIZATION OF VIROLOGIC ESCAPE IN HCV GENOTYPE 1 NULL RESPONDERS RECEIVING A COMBINATION OF THE NS3 PROTEASE INHIBITOR BMS-650032 AND NS5A INHIBITOR BMS-790052

✍ Scribed by F. McPhee; D. Hernandez; F. Yu; J. Ueland; C. Wang; H. Huang; D. Gardiner; R. Fridell; M. Gao

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

14 DUAL ORAL THERAPY WITH THE NS5A INHIB

✍ F. Suzuki; K. Ikeda; J. Toyota; Y. Karino; T. Ohmura; K. Chayama; S. Takahashi; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Prevalence of hepatitis C virus variants

✍ Fumitaka Suzuki; Hitomi Sezaki; Norio Akuta; Yoshiyuki Suzuki; Yuya Seko; Yusuke 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 156 KB

1223 NO EARLY VIROLOGIC BREAKTHROUGH OBS

✍ McPhee, F.; Sheaffer, A.; Yu, F.; Lee, M.; Chaniewski, S.; Falk, P.; Pasquinelli 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 41 KB

1189 ONCE-DAILY NS5A INHIBITOR (BMS-7900

✍ Pol, S.; Everson, G.; Ghalib, R.; Rustgi, V.; Martorell, C.; Tatum, H.A.; Lim, J 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 52 KB

1415 CONFIRMATION THAT QUADRUPLE THERAPY

✍ Lok, A.; Gardiner, D.; Hezode, C.; Lawitz, E.; Bourliere, M.; Everson, G.; Marce 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 59 KB

1373 FIRST REPORT OF SVR12 FOR A NS5A RE

✍ Pol, S.; Ghalib, R.H.; Rustgi, V.K.; Martorell, C.; Everson, G.T.; Tatum, H.A.; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 59 KB